RA

Reehan Ahmad

Active Director Director DIN 10669120
DIN 10669120 First appointment Jun 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Reehan Ahmad

Data last updated:

Reehan Ahmad is a Director at Z Plus Life Sciences Private Limited (since 2024). Z Plus Life Sciences Private Limited reported revenue of ₹10.1 Lakh (FY 2025).

DIN 10669120
Primary Designation Director
First Appointment 14 Jun 2024
Oldest Company Age 2 yrs
Largest company Z Plus Life Sciences Private Limited · ₹10.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Z Plus Life Sciences Private Limited U47721UP2024PTC204641
Director14 Jun 20242024₹10.1 Lakh (FY 2025)Active

Board colleagues of Reehan Ahmad

NameDINCompanyDesignation
Shabina Khan10669119Z Plus Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Z Plus Life Sciences Private Limited
Premium access

Shareholding and investment profile for Reehan Ahmad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reehan Ahmad

Reehan Ahmad currently holds 1 directorship: Z Plus Life Sciences Private Limited (Director, since 14 Jun 2024, revenue ₹10.1 Lakh (FY 2025)).

Reehan Ahmad was first appointed on 14 Jun 2024 as Director at Z Plus Life Sciences Private Limited.

The current boards of Reehan Ahmad's companies include Shabina Khan (Z Plus Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available